Inappropriately classified in the past as Leiomyomas, Leiomyoblastomas, and Schwannomas, in the late 1990s they were classified as a single neoplastic entity, when immunohistochemistry had identified the gene KIT (CD117) [2]. The gene discussed is KIT; the disease is leiomyoma.